In mSOD1G93A mice, the increased expression of c-Abl protein was accompanied by an increase in its active phosphorylated form, thus suggesting that c-Abl could represent a potential therapeutic target for ALS. Here, ABL1 is linked to amyotrophic lateral sclerosis.